Oscar A Jofre, CEO and Co-Founder, leads a session on March 23rd with an overview of the technology behind the All-In-One Platform for private capital markets
KoreConX is pleased to announce once again its supporting sponsorship for the LSI Emerging Medtech Summit 2023, which takes place in Dana Point, California, starting next week. This is the first edition of the year, with the mission to connect innovators and investors.
Oscar A Jofre, Co-founder and CEO of KoreConX, is a proud sponsor, supporter, and speaker at the event. “Both KoreConX and Life Science Intelligence (LSI) are innovator’s companies. That is why it is so natural for us to be connected. Companies need to raise capital compliantly to keep the MedTech ecosystem blooming, and we can definitely help. We want to be part of the solution”.
LSI is part of the MedTech ecosystem led by KoreConX. This ecosystem brings experts together to drive innovation while helping MedTech leaders access the community, capital, and insights to enable growth. As an essential part of this vertical, LSI’s team of market researchers, economists, and analysts provide valuable insights and data to help investors and executives make informed decisions.
LSI Emerging Medtech Summit 2023 will occur from March 20th to 23rd, and attendees can participate in person or online. Registration is still open on the website, with limited spots remaining. For the full schedule, speakers, keynotes, and any registrations visit the event website.
Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution.